-+ 0.00%
-+ 0.00%
-+ 0.00%

Mizuho Maintains Outperform on Corbus Pharmaceuticals, Lowers Price Target to $34

Benzinga·06/23/2026 15:05:39
Listen to the news
Mizuho analyst Graig Suvannavejh maintains Corbus Pharmaceuticals (NASDAQ:CRBP) with a Outperform and lowers the price target from $44 to $34.